380 related articles for article (PubMed ID: 21310382)
1. Bilateral irreversible severe vision loss from cosmetic iris implants.
George MK; Tsai JC; Loewen NA
Am J Ophthalmol; 2011 May; 151(5):872-875.e1. PubMed ID: 21310382
[TBL] [Abstract][Full Text] [Related]
2. Uveitis-glaucoma-hyphema syndrome and corneal decompensation in association with cosmetic iris implants.
Arthur SN; Wright MM; Kramarevsky N; Kaufman SC; Grajewski AL
Am J Ophthalmol; 2009 Nov; 148(5):790-3. PubMed ID: 19660735
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases.
Wakabayashi T; Oshima Y; Sakaguchi H; Ikuno Y; Miki A; Gomi F; Otori Y; Kamei M; Kusaka S; Tano Y
Ophthalmology; 2008 Sep; 115(9):1571-80, 1580.e1-3. PubMed ID: 18440643
[TBL] [Abstract][Full Text] [Related]
4. Serious ocular complications of cosmetic iris implants in 14 eyes.
Hoguet A; Ritterband D; Koplin R; Wu E; Raviv T; Aljian J; Seedor J
J Cataract Refract Surg; 2012 Mar; 38(3):387-93. PubMed ID: 22244609
[TBL] [Abstract][Full Text] [Related]
5. Management of neovascular glaucoma with panretinal photocoagulation, intravitreal bevacizumab, and subsequent trabeculectomy with mitomycin C.
Alkawas AA; Shahien EA; Hussein AM
J Glaucoma; 2010 Dec; 19(9):622-6. PubMed ID: 20179624
[TBL] [Abstract][Full Text] [Related]
6. [Intravitreal bevacizumab for treatment of neovascular glaucoma. Report of 20 cases].
Douat J; Auriol S; Mahieu-Durringer L; Ancèle E; Pagot-Mathis V; Mathis A
J Fr Ophtalmol; 2009 Nov; 32(9):652-63. PubMed ID: 19892433
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal bevacizumab for ahmed glaucoma valve implantation in neovascular glaucoma: a case report.
Sothornwit N
J Med Assoc Thai; 2008; 91 Suppl 1():S162-5. PubMed ID: 18672609
[TBL] [Abstract][Full Text] [Related]
8. Bevacizumab as adjuvant for neovascular glaucoma.
Beutel J; Peters S; Lüke M; Aisenbrey S; Szurman P; Spitzer MS; Yoeruek E; ; Grisanti S
Acta Ophthalmol; 2010 Feb; 88(1):103-9. PubMed ID: 18811641
[TBL] [Abstract][Full Text] [Related]
9. Ahmed glaucoma valve implantation for neovascular glaucoma after vitrectomy for proliferative diabetic retinopathy.
Park UC; Park KH; Kim DM; Yu HG
J Glaucoma; 2011 Sep; 20(7):433-8. PubMed ID: 20852440
[TBL] [Abstract][Full Text] [Related]
10. Ocular neovascularization associated with central and hemicentral retinal vein occlusion.
Hayreh SS; Zimmerman MB
Retina; 2012 Sep; 32(8):1553-65. PubMed ID: 22495331
[TBL] [Abstract][Full Text] [Related]
11. In vivo corneal endothelial safety of intracameral bevacizumab and effect in neovascular glaucoma combined with Ahmed valve implantation.
Shin JP; Lee JW; Sohn BJ; Kim HK; Kim SY
J Glaucoma; 2009; 18(8):589-94. PubMed ID: 19826387
[TBL] [Abstract][Full Text] [Related]
12. Intravitreal bevacizumab and aqueous shunting surgery for neovascular glaucoma: safety and efficacy.
Eid TM; Radwan A; el-Manawy W; el-Hawary I
Can J Ophthalmol; 2009 Aug; 44(4):451-6. PubMed ID: 19606170
[TBL] [Abstract][Full Text] [Related]
13. [Results of trabeculectomy with anti-VGEF therapy in the treatment of neovascular glaucoma secondary to retinal vein occlusion (report of 21 cases followed at Bukavu Eye Clinic from January 1 to December 31th, 2015)].
Kabesha TB; Kabesha D; Maloba V; Mwamba C; Chenge B; Mukalay A
J Fr Ophtalmol; 2017 Jan; 40(1):17-21. PubMed ID: 27884546
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of treatment of neovascular glaucoma with intravitreal bevacizumab.
Moraczewski AL; Lee RK; Palmberg PF; Rosenfeld PJ; Feuer WJ
Br J Ophthalmol; 2009 May; 93(5):589-93. PubMed ID: 19074917
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal bevacizumab (Avastin) in the treatment of neovascular glaucoma.
Iliev ME; Domig D; Wolf-Schnurrbursch U; Wolf S; Sarra GM
Am J Ophthalmol; 2006 Dec; 142(6):1054-6. PubMed ID: 17157590
[TBL] [Abstract][Full Text] [Related]
16. Intracameral bevacizumab (Avastin) for neovascular glaucoma: a pilot study in 6 patients.
Duch S; Buchacra O; Milla E; Andreu D; Tellez J
J Glaucoma; 2009 Feb; 18(2):140-3. PubMed ID: 19225351
[TBL] [Abstract][Full Text] [Related]
17. Five-slice technique for the explantation of complicated BrightOcular© cosmetic iris implants.
Shalash A; El Bahrawy M
Int Ophthalmol; 2020 Jun; 40(6):1565-1570. PubMed ID: 32166580
[TBL] [Abstract][Full Text] [Related]
18. Vitrectomy and panretinal photocoagulation reduces the occurrence of neovascular glaucoma in central retinal vein occlusion with vitreous hemorrhage.
Chuang LH; Wang NK; Chen YP; Yeung L; Hwang YS; Chen KJ; Wu WC; Chen TL; Lai CC
Retina; 2013 Apr; 33(4):798-802. PubMed ID: 23114407
[TBL] [Abstract][Full Text] [Related]
19. Case-matched comparison of vitrectomy, peripheral retinal endolaser, and endocyclophotocoagulation versus standard care in neovascular glaucoma.
Marra KV; Wagley S; Omar A; Kinoshita T; Kovacs KD; Silva P; Kuperwaser MC; Arroyo JG
Retina; 2015 Jun; 35(6):1072-83. PubMed ID: 25621944
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of intravitreal bevacizumab with panretinal photocoagulation followed by Ahmed valve implantation in neovascular glaucoma.
Mahdy RA; Nada WM; Fawzy KM; Alnashar HY; Almosalamy SM
J Glaucoma; 2013 Dec; 22(9):768-72. PubMed ID: 22790513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
